Home

bandiera nazionale perturbazione Di Più nejm images in clinical medicine impact factor Contrarre vicolo presentazione

bjoern.brembs.blog » New England Journal of Medicine – and you thought  Nature was expensive?
bjoern.brembs.blog » New England Journal of Medicine – and you thought Nature was expensive?

New England Journal of Medicine on Ovid | Wolters Kluwer
New England Journal of Medicine on Ovid | Wolters Kluwer

Fixing Burnout Through Physician Input
Fixing Burnout Through Physician Input

Understanding and Mitigating Health Inequities — Past, Current, and Future  Directions | NEJM
Understanding and Mitigating Health Inequities — Past, Current, and Future Directions | NEJM

The New England Journal of Medicine - The new impact factor for NEJM is  54.42 (up 5%). Thank you to all of our authors, and to all of the patients  who participate
The New England Journal of Medicine - The new impact factor for NEJM is 54.42 (up 5%). Thank you to all of our authors, and to all of the patients who participate

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Misrepresenting Race — The Role of Medical Schools in Propagating Physician  Bias | NEJM
Misrepresenting Race — The Role of Medical Schools in Propagating Physician Bias | NEJM

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes |  NEJM
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes | NEJM

Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media |  NEJM
Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media | NEJM

🏆 The New England Journal of Medicine | Impact Factor | Indexing |  Acceptance rate | Abbreviation - Open access journals
🏆 The New England Journal of Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals

Implanted System for Orthostatic Hypotension in Multiple-System Atrophy |  NEJM
Implanted System for Orthostatic Hypotension in Multiple-System Atrophy | NEJM

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM

Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with  Covid-19 | NEJM
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM

The world's top medical journals
The world's top medical journals

The Future of Public Health | NEJM
The Future of Public Health | NEJM

Perspective: The intersection of public health and clinical medicine is  changing | News | Harvard T.H. Chan School of Public Health
Perspective: The intersection of public health and clinical medicine is changing | News | Harvard T.H. Chan School of Public Health

The New England Journal of Medicine: Research & Review Articles on Disease  & Clinical Practice
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice

Coronavirus (Covid-19) — NEJM
Coronavirus (Covid-19) — NEJM

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity  | NEJM
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity | NEJM

Gastroenterology articles: The New England Journal of Medicine
Gastroenterology articles: The New England Journal of Medicine

Aspergillus Infections | NEJM
Aspergillus Infections | NEJM

Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center |  NEJM
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM

Rapid Diagnostic Testing for SARS-CoV-2 | NEJM
Rapid Diagnostic Testing for SARS-CoV-2 | NEJM

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD  | NEJM
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD | NEJM